References
Original article
Koehm, M. et al. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial. Lancet Rheumatol. 5, e14–e23 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Onuora, S. No benefit from adding MTX to ustekinumab. Nat Rev Rheumatol 19, 129 (2023). https://doi.org/10.1038/s41584-023-00912-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-023-00912-w
- Springer Nature Limited